Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sposito AC"'
Autor:
Lukhna K; Division of Cardiology, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., do Carmo HRP; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Castillo AR; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Davidson SM; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Geffen H; Division of Cardiology, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Giesz S; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Golforoush P; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Bovi TG; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Gorag D; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Salama A; Cape Heart Institute, University of Cape Town, Cape Town, South Africa.; The Royal Free Hospital, University College London, Pond St, London, NW3 2QG, UK., Imamdin A; Cape Heart Institute, University of Cape Town, Cape Town, South Africa., Kalkhoran S; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Lecour S; Cape Heart Institute, University of Cape Town, Cape Town, South Africa., Perroud MW Jr; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Ntsekhe M; Division of Cardiology, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Sposito AC; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Yellon DM; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac.uk.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Jun; Vol. 38 (3), pp. 433-445. Date of Electronic Publication: 2022 Nov 29.
Autor:
Davidson SM; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Lukhna K; Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Gorog DA; Postgraduate Medicine, University of Hertfordshire, UK & East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK., Salama AD; Department of Renal Medicine, Royal Free Hospital, London, UK., Castillo AR; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Giesz S; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Golforoush P; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Kalkhoran SB; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK., Lecour S; The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa., Imamdin A; The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa., do Carmo HRP; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Bovi TG; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Perroud MW Jr; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Ntsekhe M; Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Sposito AC; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Yellon DM; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac.uk.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2022 Oct; Vol. 36 (5), pp. 925-930. Date of Electronic Publication: 2021 Jun 25.
Autor:
Davidson SM; The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK., Lukhna K; Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Gorog DA; Postgraduate Medicine, University of Hertfordshire, UK & East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK., Salama AD; Department of Renal Medicine, Royal Free Hospital, London, UK., Castillo AR; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Giesz S; The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK., Golforoush P; The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK., Kalkhoran SB; The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK., Lecour S; The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa., Imamdin A; The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa., do Carmo HRP; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Bovi TG; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Perroud MW Jr; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Ntsekhe M; Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Sposito AC; Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil., Yellon DM; The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac.uk.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2022 Oct; Vol. 36 (5), pp. 931.
Autor:
Sposito AC; Atherosclerosis and Vascular Biology Laboratory (AtheroLab), Cardiology Department, Faculty of Medical Sciences, State University of Campinas (Unicamp), Campinas, São Paulo, 13084-971, Brazil. andreisposito@gmail.com., Carmo HR; Atherosclerosis and Vascular Biology Laboratory (AtheroLab), Cardiology Department, Faculty of Medical Sciences, State University of Campinas (Unicamp), Campinas, São Paulo, 13084-971, Brazil., Barreto J; Atherosclerosis and Vascular Biology Laboratory (AtheroLab), Cardiology Department, Faculty of Medical Sciences, State University of Campinas (Unicamp), Campinas, São Paulo, 13084-971, Brazil., Sun L; National Heart, Lung and Blood Institute, National Institutes of Health, 10 Center Dr. Building 10 8N222, Bethesda, MD, USA., Carvalho LSF; Atherosclerosis and Vascular Biology Laboratory (AtheroLab), Cardiology Department, Faculty of Medical Sciences, State University of Campinas (Unicamp), Campinas, São Paulo, 13084-971, Brazil., Feinstein SB; Division of Cardiology, Rush University Medical Center, Chicago, IL, USA., Zanotti I; Department of Pharmacy, University of Parma, Parma, Italy., Kontush A; INSERM UMR-S 1166, Faculte de Medecine Pitie-Salpetriere, University of Pierre and Marie Curie - Paris 6, Paris, France., Remaley A; National Heart, Lung and Blood Institute, National Institutes of Health, 10 Center Dr. Building 10 8N222, Bethesda, MD, USA.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2019 Jun; Vol. 33 (3), pp. 371-381.